Table 1: Clinical characteristic, treatment and outcome in STEMI.

VARIABLE

TOTAL

MALE

FEMALE

P VALUE

N

510

336 (65.8%)

 174 (34.2)

<0.001

CLINICAL CHARACTERISTIC

 MEAN AGE

55.8 yrs

53.6 yrs

58 yrs

    <.001

SMOKER

235 (46.07)

227 (67.5%)

8 (4.5%)

   <0.001

HYPERTENSION

210 (41.1%)

122 (36.3%)

88 (50.5%)

   <0.001

DIABETES

174 (34.1%)

91 (27.08%)

83 (47.7%)

  <0.001

BMI>25

135 (26.4%)

66 (19.6%)

69 (39.6%)

    0.003

H/O OF PREVIOUS MI

88 (17.25%)

45 (13.3%)

33 (18.91%)

      0.11

DYSLIPIDEMIA

170 (33.3%)

89 (26.4%)

81 (46.5%)

    0.001

MEAN TIME TO PRESENTATION

9.98 hrs

9.51 hrs

10.46 hrs

      0.26

ATYPICAL PRESENTATION

102 (20%)

 47 (13.98%)

 57 (31.6%)

   <0.001

TREATMENT IN HOSPITAL

ASPIRIN

506 (99.2%)

334 (99.4%)

172 (98.8%)

    0.6

CLOPIDOGREL

502 (98.4%)

332 (98.8%)

170 (97.7%)

    0.45

STATINS

506 (99.2%)

334 (99.4%)

172 (98.8%)

    0.6

ACEI/ARB

459 (90.1%)

301 (89.5%)

158 (90.8%)

    0.75

Beta blockers

456 (89.4%)

300 (89.2%)

156 (89.6%)

    1.00

LMWH

496 (98.4%)

327 (97.3%)

169 (97.1%)

    1.00

Thrombolysis

199 (39.1%)

150 (44.34%)

50 (28.73%)

    0.04

PCI

75 (14.7%)

59 (17.5%)

16 (9.1%)

    0.01

OUTCOME AT 30 DAYS

HEART FAILURE/

CARDIOGENIC SHOCK

65 (12.7%)

35 (10.41%)

30 (17.2%)

      0.03

REINFARCTION

34 (6.66%)

18 (5.35%)

16 (9.1%)

    0.13

CARDIAC ARREST (resuscitated)

33 (6.47%),

17 (5.05%)

16 (9.1%)

    0.08

STROKE

3 (0.58%)

3 (0.89%)

0%

    0.55

DEATH

60 (11.76%)

33 (9.8%)

27 (15.51%)

    0.06

Cause

of

death

Pump failure

27 (45%)

14 (42.4%)

13 (48.1%)

    0.14

Asystole

10 (18.51%)

 6 (18.1%)

4 (14.81%)

    0.74

VF

10 (18.51%)

6 (18.1%)

4 (14.81%)

    0.74

Multifactorial

13 (24%)

7 (21.21%)

06 (22.2%)

    0.38